News2418h
Which of the breakthrough weight-loss medicines can you get in SA?
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
Healio20h
Preconception GLP-1 receptor agonist use may reduce pregnancy risks
Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...
Diabetes Drug Market Size to Surpass USD 145 Billion by 2032 at a CAGR of 6.9%, Fueled by Rising Global Diabetes Prevalence – SNS Insider
Global Diabetes Drug Market growth is driven by the rising incidence of diabetes and increasing adoption of innovative treatment solutions.Austin, United States, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ...